Petersen, Desiree C.
Jaratlerdsiri, Weerachai
van Wyk, Abraham
Chan, Eva K. F.
Fernandez, Pedro
Lyons, Ruth J.
Mutambirw, Shingai B. A.
van der Merwe, Andre
Venter, Philip A.
Bates, William
Bornman, M. S. Riana
Hayes, Vanessa M. http://orcid.org/0000-0002-4524-7280
Funding for this research was provided by:
Sydney Medical School (Petre Chair)
Prostate Cancer Foundation of Australia (MRTA ProMis)
Article History
Received: 16 December 2018
Accepted: 21 May 2019
First Online: 4 June 2019
Ethics approval and consent to participate
: Participants were recruited and performed written consent according to research ethics approvals granted from the Provincial Government of Limpopo (#32/2008) and the University of Limpopo Medical Research Ethics Committee (#MREC/H/28/2009), the University of Pretoria Human Research Ethics Committee (HREC #43/2010, including US Federal wide assurance FWA00002567 and IRB00002235 IORG0001762), Stellenbosch University HREC (#N08/03/072) or the SANBS HREC (#2012/11). DNA was shipped to Australia under the Republic of South Africa Department of Health Export Permits in accordance with the National Health Act 2003 (J1/2/4/2 #1/10, #1/12 and #3/15) and as per institutional Material Transfer Agreements. Genomic interrogation was performed in accordance with St Vincent’s Hospital (SVH) HREC site-specific approval (#SVH15/227).
: Not applicable.
: The authors declare that they have no competing interests.